Literature DB >> 8058092

Achilles tendinitis and tendon rupture due to fluoroquinolone antibiotics.

K A Huston.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1994        PMID： 8058092     DOI： 10.1056/NEJM199409153311116

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  16 in total

1.  Fluoroquinolones and risk of Achilles tendon disorders: case-control study.

Authors:  P D van der Linden; M C J M Sturkenboom; R M C Herings; H G M Leufkens; B H Ch Stricker
Journal:  BMJ       Date:  2002-06-01

Review 2.  Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.

Authors:  Thomas J Hannan; Makrina Totsika; Kylie J Mansfield; Kate H Moore; Mark A Schembri; Scott J Hultgren
Journal:  FEMS Microbiol Rev       Date:  2012-05       Impact factor: 16.408

3.  The Risk of Fluoroquinolone-induced Tendinopathy and Tendon Rupture: What Does The Clinician Need To Know?

Authors:  Grace K Kim
Journal:  J Clin Aesthet Dermatol       Date:  2010-04

4.  Evidence of tendinitis provoked by fluoroquinolone treatment: a case-control study.

Authors:  Giovanni Corrao; Antonella Zambon; Lorenza Bertù; Anna Mauri; Valentina Paleari; Camillo Rossi; Mauro Venegoni
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

5.  A reappraisal of quinolone tolerability. The experience of their musculoskeletal adverse effects.

Authors:  G Hayem; C Carbon
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

Review 6.  Corticosteroid-associated tendinopathies: an analysis of the published literature and spontaneous pharmacovigilance data.

Authors:  Irene Blanco; Stephan Krähenbühl; Raymond G Schlienger
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 7.  Enoxacin: a reappraisal of its clinical efficacy in the treatment of genitourinary tract infections.

Authors:  S S Patel; C M Spencer
Journal:  Drugs       Date:  1996-01       Impact factor: 9.546

8.  Patients at Risk for Aortic Rupture Often Exposed to Fluoroquinolones during Hospitalization.

Authors:  William C Frankel; Barbara W Trautner; Andrew Spiegelman; Larissa Grigoryan; Scott A LeMaire
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

9.  Quinolone-associated tendonitis: a potential problem in COPD?

Authors:  M W Butler; J F Griffin; W R Quinlan; T J McDonnell
Journal:  Ir J Med Sci       Date:  2001 Jul-Sep       Impact factor: 1.568

10.  Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three italian regions.

Authors:  Roberto Leone; Mauro Venegoni; Domenico Motola; Ugo Moretti; Valentina Piazzetta; Alfredo Cocci; Domenico Resi; Federico Mozzo; Giampaolo Velo; Liliana Burzilleri; Nicola Montanaro; Anita Conforti
Journal:  Drug Saf       Date:  2003       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.